r.petrov

TL2 Moderator · Tilburg

Contributes reviews on supplier material. Based in Tilburg.

Joined 18 August 2025 · last posted 6d

75 posts, newest first. Showing up to 150.

Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #98 · Start Here › Welcome · 22 Jul 2026 · 5 likes Picking up post #95: that is the part I would want checked first. The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not…
Aggregate verification data across the directory, with caveats Replied, post #63 · Sourcing › Independent verification · 22 Jul 2026 · 5 likes Picking up post #60: that is the part I would want checked first. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials.…
Here for the analytics and not much else Replied, post #71 · Lounge › Introductions · 22 Jul 2026 · 25 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community.
Ultrasound and skinfolds: operator dependence in practice Replied, post #67 · Outcomes › Body composition · 20 Jul 2026 · 7 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #78 · Evidence › Journal club · 17 Jul 2026 · 24 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
Publication patterns in the BPC-157 literature, examined Replied, post #36 · Compounds › Repair & healing peptides · 15 Jul 2026 · 0 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
Alcohol: what is documented and what is folklore Replied, post #102 · Practice › Interactions · 9 Jul 2026 · 28 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
Request: a per-category review queue Replied, post #51 · Meta › Feature requests · 21 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
What would change my mind about repair peptides: a specific answer Replied, post #7 · Compounds › Repair & healing peptides · 7 Jun 2026 · 14 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
Official shortage notices and what they authorise Replied, post #59 · Access › Shortages · 20 May 2026 · 7 likes I read post #57 twice before replying, because I had assumed the opposite. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and…
A parcel stationary at a customs facility for nine days Replied, post #61 · Sourcing › Logistics · 19 May 2026 · 2 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #51 · Evidence › Preprints · 12 May 2026 · 0 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
Alcohol: what is documented and what is folklore Replied, post #2 · Practice › Interactions · 3 May 2026 · 24 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
Request: show the solution author in the topic list — what changed since Replied, post #65 · Meta › Feature requests · 3 May 2026 · 0 likes Community support: if other people support your request, they can reply with "+1" or "I would use that too". Widely-requested features are prioritised.
GLP-1 receptor distribution: central and peripheral Replied, post #30 · Pharmacology › Receptor biology · 11 Apr 2026 · 2 likes Coming back to post #28, because the follow-up matters more than the original answer. Bias and desensitisation: receptors can be biased (preferentially activating some…
Spike-and-recover accuracy for a peptide assay Replied, post #99 · Analytics › Method validation · 10 Apr 2026 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #16 · Compounds › Semaglutide · 6 Apr 2026 · 11 likes I read post #14 twice before replying, because I had assumed the opposite. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #112 · Pharmacology › Pharmacokinetics · 22 Mar 2026 · 0 likes post #111 is right about the mechanism and I think understates the practical bit. Fasting requirement for oral semaglutide: food and large fluid volumes reduce…
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #57 · Compounds › Cagrilintide & amylin analogues · 11 Mar 2026 · 0 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #12 · Practice › Dosing & titration · 10 Mar 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #65 · Analytics › Impurities & related substances · 19 Feb 2026 · 0 likes Coming back to post #63, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Micro-titration: a disputed topic, argued properly Replied, post #29 · Practice › Dosing & titration · 1 Feb 2026 · 0 likes Worth separating two things that post #25 runs together. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #52 · Practice › Storage & stability · 17 Jan 2026 · 5 likes Coming back to post #50, because the follow-up matters more than the original answer. Vial integrity: once a vial is entered with a needle repeatedly, the rubber…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #48 · Sourcing › Red flags · 13 Jan 2026 · 19 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
Second pass at: Programming during a large energy deficit Replied, post #94 · Nutrition & Training › Resistance training · 23 Nov 2025 · 17 likes Picking up post #91: that is the part I would want checked first. Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires…
Pooling trials with different estimands — what changed since Replied, post #55 · Evidence › Meta-analyses · 23 Nov 2025 · 26 likes This follows post #52 rather than contradicting it. Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies…
Lurking for two months before posting: was that the right call? Replied, post #10 · Start Here › Welcome · 17 Nov 2025 · 11 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
Robustness: the parameters worth deliberately varying Replied, post #4 · Analytics › Method validation · 16 Nov 2025 · 0 likes This follows post #3 rather than contradicting it. Why two laboratories may disagree: after validating the same method, they may still report different purity on the…
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #35 · Sourcing › Vendor reports · 15 Nov 2025 · 3 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #8 · Analytics › Impurities & related substances · 14 Nov 2025 · 28 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #15 · Analytics › Method validation · 13 Nov 2025 · 0 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
Cross-border purchase rules within the EU Replied, post #35 · Regional › European Union · 7 Nov 2025 · 8 likes Coming back to post #33, because the follow-up matters more than the original answer. Cross-border purchase rules: buying a prescription in one EU country and bringing…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #9 · Pharmacology › Pharmacokinetics · 26 Oct 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Where to report an adverse event officially, by region — a second dataset Replied, post #52 · Safety › Adverse events · 24 Oct 2025 · 0 likes How to document: date, exact symptom or event, severity, duration, outcome, any medical attention sought. Detailed documentation is far more useful than a vague report.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #12 · Compounds › Oral incretins · 20 Oct 2025 · 8 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Payment mechanics and the recovery options that do not exist Replied, post #15 · Sourcing › Payments · 19 Oct 2025 · 9 likes post #14 is right about the mechanism and I think understates the practical bit. Currency conversion: payment in your local currency often involves a conversion fee.…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #74 · Evidence › Preprints · 1 Oct 2025 · 18 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Temperature loggers worth the money — the long version Replied, post #47 · Devices › Cold chain · 27 Sep 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
What a 2 ppm match establishes, and what it does not Replied, post #51 · Analytics › Mass spectrometry · 16 Sep 2025 · 8 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
How to read a forest plot, properly, from scratch Replied, post #27 · Evidence › Trials · 13 Sep 2025 · 10 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #126 · Compounds › Secretagogues & GH axis · 2 Sep 2025 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Second pass at: The mass-error checker and its intended scope Replied, post #7 · marked as the solution · Data & Tools › Calculators · 28 Aug 2025 · 7 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
Managing an unplanned gap in supply — what changed since Replied, post #42 · Access › Shortages · 20 Aug 2025 · 5 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
Why oral semaglutide needs an absorption enhancer at all Replied, post #20 · Compounds › Oral incretins · 22 Jul 2025 · 22 likes Worth separating two things that post #16 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #19 · Practice › Administration · 20 Jul 2025 · 7 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
Request: a diff view for wiki revisions — the long version Replied, post #18 · Meta › Feature requests · 12 Jul 2025 · 0 likes post #17 is right about the mechanism and I think understates the practical bit. Effort estimation: some features are trivial to implement; others are substantial work.…
Sequence verification for an obscure compound: how it is done Replied, post #79 · Compounds › Other compounds · 1 Jul 2025 · 2 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
Reading a chromatogram someone posted without axes Replied, post #51 · Analytics › HPLC & UHPLC · 27 Jun 2025 · 22 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #69 · Pharmacology › Pharmacokinetics · 27 Jun 2025 · 3 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
Reading a supplier's product description as a marketing document Replied, post #33 · Compounds › Other compounds · 14 Jun 2025 · 27 likes Worth separating two things that post #29 runs together. Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #53 · Clinical › Comorbidities · 31 May 2025 · 18 likes post #52 is right about the mechanism and I think understates the practical bit. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #16 · Practice › Dosing & titration · 26 May 2025 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Adjudicated events and why the definition matters — the long version Replied, post #147 · Evidence › Trials · 10 May 2025 · 8 likes Picking up post #144: that is the part I would want checked first. Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #19 · Sourcing › Independent verification · 27 Apr 2025 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
Reading a trial's population section before its results — does this still hold? Replied, post #41 · Evidence › Trials · 26 Apr 2025 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #16 · Evidence › Trials · 23 Apr 2025 · 5 likes post #15 answers the question as asked. The question underneath it is different. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #7 · Evidence › Trials · 6 Apr 2025 · 5 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #31 · Practice › Interactions · 30 Mar 2025 · 19 likes I read post #29 twice before replying, because I had assumed the opposite. Separation timing versus clinically important interaction: a separation timing inconvenience…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #45 · Evidence › Journal club · 15 Mar 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Adjudicated events and why the definition matters — the long version Replied, post #35 · Evidence › Trials · 6 Mar 2025 · 0 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
Consistent declarations and why they matter more than clever ones Replied, post #133 · Sourcing › Logistics · 6 Mar 2025 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #21 · Devices › Syringes & needles · 20 Jan 2025 · 5 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #14 · Clinical › Bloodwork · 10 Jan 2025 · 32 likes I read post #12 twice before replying, because I had assumed the opposite. Biological variation: the person-to-person variation in a biomarker for a healthy person is…
What changed in 2026, by region Replied, post #62 · Access › International · 7 Jan 2025 · 6 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
Pancreatitis history and the risk calculus — a second dataset Replied, post #16 · Safety › Contraindications · 12 Dec 2024 · 12 likes Worth separating two things that post #12 runs together. History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #38 · Practice › Reconstitution · 6 Dec 2024 · 3 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #123 · Compounds › Other compounds · 17 Nov 2024 · 0 likes On post #119 — agreed on the reasoning, with one qualification. This subcategory exists because some people will research compounds outside the main groups discussed…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #19 · Compounds › Repair & healing peptides · 9 Nov 2024 · 28 likes Worth separating two things that post #15 runs together. Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research…
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #2 · Pharmacology › Formulation chemistry · 17 Oct 2024 · 11 likes Lyophilisation and reconstitution: the powder is stable for extended periods if kept cool and dry. Once reconstituted, stability decreases because the dissolved peptide…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #81 · Practice › Administration · 5 Oct 2024 · 0 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #10 · Compounds › Other compounds · 20 Sep 2024 · 0 likes On post #6 — agreed on the reasoning, with one qualification. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #47 · Nutrition & Training › Hydration & electrolytes · 18 Aug 2024 · 1 like Water intoxication: drinking excessive water (more than a few liters per day for extended time) without electrolyte replacement can cause hyponatremia. This is rare but…
Guidelines revision: what changed and why Replied, post #19 · Meta › Announcements · 25 Jul 2024 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Journal club: FLOW and the renal composite, component by component Replied, post #53 · Evidence › Journal club · 14 Jul 2024 · 8 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #127 · Practice › Dosing & titration · 10 Jul 2024 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…